216 related articles for article (PubMed ID: 31687076)
1. NRF1 and NRF2 mRNA and Protein Expression Decrease Early during Melanoma Carcinogenesis: An Insight into Survival and MicroRNAs.
Hämäläinen M; Teppo HR; Skarp S; Haapasaari KM; Porvari K; Vuopala K; Kietzmann T; Karihtala P
Oxid Med Cell Longev; 2019; 2019():2647068. PubMed ID: 31687076
[TBL] [Abstract][Full Text] [Related]
2. NRF3 Decreases during Melanoma Carcinogenesis and Is an Independent Prognostic Marker in Melanoma.
Immonen A; Haapasaari KM; Skarp S; Karihtala P; Teppo HR
Oxid Med Cell Longev; 2022; 2022():2240223. PubMed ID: 35378827
[TBL] [Abstract][Full Text] [Related]
3. Nuclear factor erythroid 2-related factors 1 and 2 are able to define the worst prognosis group among high-risk diffuse large B cell lymphomas treated with R-CHOEP.
Kari E; Teppo HR; Haapasaari KM; Kuusisto MEL; Lemma A; Karihtala P; Pirinen R; Soini Y; Jantunen E; Turpeenniemi-Hujanen T; Kuittinen O
J Clin Pathol; 2019 Apr; 72(4):316-321. PubMed ID: 30755497
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-153 Regulates NRF2 Expression and is Associated with Breast Carcinogenesis.
Wang B; Teng Y; Liu Q
Clin Lab; 2016; 62(1-2):39-47. PubMed ID: 27012032
[TBL] [Abstract][Full Text] [Related]
5. Expression of microRNA-106b and its clinical significance in cutaneous melanoma.
Lin N; Zhou Y; Lian X; Tu Y
Genet Mol Res; 2015 Dec; 14(4):16379-85. PubMed ID: 26662433
[TBL] [Abstract][Full Text] [Related]
6. Expression Levels of microRNAs miR-93 and miR-200a in Pancreatic Adenocarcinoma with Special Reference to Differentiation and Relapse-Free Survival.
Karihtala P; Porvari K; Soini Y; Eskelinen M; Juvonen P; Haapasaari KM
Oncology; 2019; 96(3):164-170. PubMed ID: 30537722
[TBL] [Abstract][Full Text] [Related]
7. Differential and overlapping targets of the transcriptional regulators NRF1, NRF2, and NRF3 in human cells.
Liu P; Kerins MJ; Tian W; Neupane D; Zhang DD; Ooi A
J Biol Chem; 2019 Nov; 294(48):18131-18149. PubMed ID: 31628195
[TBL] [Abstract][Full Text] [Related]
8. Nrf2/Keap1 Pathway and Expression of Oxidative Stress Lesions 8-hydroxy-2'-deoxyguanosine and Nitrotyrosine in Melanoma.
Hintsala HR; Jokinen E; Haapasaari KM; Moza M; Ristimäki A; Soini Y; Koivunen J; Karihtala P
Anticancer Res; 2016 Apr; 36(4):1497-506. PubMed ID: 27069125
[TBL] [Abstract][Full Text] [Related]
9. SNPs at miR-155 binding sites of TYRP1 explain discrepancy between mRNA and protein and refine TYRP1 prognostic value in melanoma.
El Hajj P; Gilot D; Migault M; Theunis A; van Kempen LC; Salés F; Fayyad-Kazan H; Badran B; Larsimont D; Awada A; Bachelot L; Galibert MD; Ghanem G; Journe F
Br J Cancer; 2015 Jun; 113(1):91-8. PubMed ID: 26068396
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma.
Satzger I; Mattern A; Kuettler U; Weinspach D; Voelker B; Kapp A; Gutzmer R
Int J Cancer; 2010 Jun; 126(11):2553-62. PubMed ID: 19830692
[TBL] [Abstract][Full Text] [Related]
11. Effect of miR-101 on proliferation and oxidative stress-induced apoptosis of breast cancer cells via Nrf2 signaling pathway.
Yi J; Huang WZ; Wen YQ; Yi YC
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8931-8939. PubMed ID: 31696480
[TBL] [Abstract][Full Text] [Related]
12. Exosome-mediated transfer of miR-222 is sufficient to increase tumor malignancy in melanoma.
Felicetti F; De Feo A; Coscia C; Puglisi R; Pedini F; Pasquini L; Bellenghi M; Errico MC; Pagani E; Carè A
J Transl Med; 2016 Feb; 14():56. PubMed ID: 26912358
[TBL] [Abstract][Full Text] [Related]
13. Detection of mRNA of Telomerase Protein in Benign Naevi and Melanomas Using RNAscope.
Baltzarsen PB; Georgsen JB; Nielsen PS; Steiniche T; Stougaard M
Appl Immunohistochem Mol Morphol; 2020 Jan; 28(1):36-41. PubMed ID: 30095463
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-93 regulates NRF2 expression and is associated with breast carcinogenesis.
Singh B; Ronghe AM; Chatterjee A; Bhat NK; Bhat HK
Carcinogenesis; 2013 May; 34(5):1165-72. PubMed ID: 23492819
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-21 expression and its pathogenetic significance in cutaneous melanoma.
Saldanha G; Potter L; Lee YS; Watson S; Shendge P; Pringle JH
Melanoma Res; 2016 Feb; 26(1):21-8. PubMed ID: 26731559
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors.
Xu Y; Brenn T; Brown ER; Doherty V; Melton DW
Br J Cancer; 2012 Jan; 106(3):553-61. PubMed ID: 22223089
[TBL] [Abstract][Full Text] [Related]
17. Negative regulation of the Nrf1 transcription factor by its N-terminal domain is independent of Keap1: Nrf1, but not Nrf2, is targeted to the endoplasmic reticulum.
Zhang Y; Crouch DH; Yamamoto M; Hayes JD
Biochem J; 2006 Nov; 399(3):373-85. PubMed ID: 16872277
[TBL] [Abstract][Full Text] [Related]
18. MiRNAs as Potential Prognostic Biomarkers for Metastasis in Thin and Thick Primary Cutaneous Melanomas.
Valentini V; Zelli V; Gaggiano E; Silvestri V; Rizzolo P; Bucalo A; Calvieri S; Grassi S; Frascione P; Donati P; Soda G; Ottini L; Richetta AG
Anticancer Res; 2019 Aug; 39(8):4085-4093. PubMed ID: 31366492
[TBL] [Abstract][Full Text] [Related]
19. CtBP2 confers protection against oxidative stress through interactions with NRF1 and NRF2.
Kainoh K; Takano R; Sekiya M; Saito K; Sugasawa T; Ma Y; Murayama Y; Sugano Y; Osaki Y; Iwasaki H; Takeuchi Y; Yahagi N; Suzuki H; Miyamoto T; Nakagawa Y; Matsuzaka T; Shimano H
Biochem Biophys Res Commun; 2021 Jul; 562():146-153. PubMed ID: 34052660
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of miR-125b in metastatic cutaneous malignant melanoma.
Glud M; Rossing M; Hother C; Holst L; Hastrup N; Nielsen FC; Gniadecki R; Drzewiecki KT
Melanoma Res; 2010 Dec; 20(6):479-84. PubMed ID: 20827223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
